Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens

NIH RePORTER · NIH · N01 · $53,311 · view on reporter.nih.gov ↗

Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

Key facts

NIH application ID: 10074416
Project number: 75N93019D00005-P00003-759301900131-2
Recipient: COLORADO STATE UNIVERSITY
Principal Investigator: RICHARD SLAYDEN
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $53,311
Award type: —
Project period: 2019-05-01 → 2020-04-30